Drreddys Laboratories | RDY - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
ANI Pharmaceuticals USD 562.3M 344.37M 2026-03
Aurora Cannabis CAD 48.04M 81.94M 2026-03
Bayer EUR 9.88B 452M 2026-03
Canopy Growth CAD 98.72M 11.51M 2026-03
Cipla INR 59.27B 1.71B 2026-03
Corcept Therapeutics USD 214.5M 16.87M 2026-03
Drreddys Laboratories INR 74.33B 1.4B 2026-03
GlaxoSmithKline GBP 5.34B 1.85B 2026-03
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Lonza CHF 2.9B 184M 2025-06
Novartis USD 9.29B 507M 2026-03
Pacira USD 172.75M 20.93M 2026-03
Phibro Animal Health USD 361.83M 29.47M 2026-03
Prestige Brands USD 206.12M 5.17M 2026-03
Richter Gedeon HUF 157.88B 6.77B 2026-03
Sun Pharmaceuticals INR 114.07B 2.96B 2025-12
Supernus Pharmaceuticals USD 1.08B 879.06M 2026-03
Teva Pharmaceutical Industries USD 3.22B 1000M 2026-03